Herbal Formula YGJDSJ Inhibits Anchorage-independent Growth and Induces Anoikis in Hepatocellular Carcinoma Bel-7402 Cells
Overview
Affiliations
Background: Based on clinical medications and related studies, we established a Yang-Gan Jie-Du Sang-Jie (YGJDSJ) herbal formula for hepatocarcinoma treatment. In present study, we evaluated the anti-cancer potential of YGJDSJ on suspension-grown human hepatocellular carcinoma Bel-7402 cells.
Methods: Bel-7402 cells were cultured in poly(2-hydroxyethyl methacrylate) (poly-HEMA) coated plates and treated with YGJDSJ. Anchorage-independent cell growth was detected by cell Counting Kit-8 (CCK-8) assay and soft agar colony formation assay. Anoikis was detected by ethdium homodimer-1 (EthD-1) staining and flow cytometry analysis. Caspases activities were detected by the cleavage of chromogenic substrate. Reactive oxygen species (ROS) was detected by 2',7'-dichlorofluorescin diacetate (DCFH-DA) staining. Protein expression and phosphorylation was identified by western blot. Protein expression was knocked-down by siRNA.
Results: YGJDSJ inhibited the proliferation of Bel-7402 cells in poly-HEMA coated plates and anchorage-independent growth of Bel-7402 cells in soft agar. YGJDSJ also induced anoikis in Bel-7402 cells as indicated by EthD-1 staining and flow cytometry analysis. YGJDSJ activated caspase-3, - 8, and - 9 in suspension-grown Bel-7402 cells. The pan-caspase inhibitor Z-VAD-FMK significantly abrogated the effects of YGJDSJ on anoikis in suspension-grown Bel-7402 cells. In addition, YGJDSJ increased ROS in suspension-grown Bel-7402 cells. The ROS scavenger N-acetyl-L-cysteine (NAC) partially attenuated YGJDSJ-induced activation of caspase-3, - 8 and - 9 and anoikis in suspension-grown Bel-7402 cells. Furthermore, YGJDSJ inhibited expression and phosphorylation of protein tyrosine kinase 2 (PTK2) in suspension-grown Bel-7402 cells. Over-expression of PTK2 significantly abrogated YGJDSJ induced anoikis.
Conclusions: YGJDSJ inhibits anchorage-independent growth and induce caspase-mediated anoikis in Bel-7402 cells, and may relate to ROS generation and PTK2 downregulation.
Roles of anoikis in hepatocellular carcinoma: mechanisms and therapeutic potential.
Chen C, Wang M, Tu D, Cao J, Zhang C, Bai D Med Oncol. 2025; 42(3):58.
PMID: 39885089 DOI: 10.1007/s12032-025-02612-9.
Regulation of pancreatic cancer metastasis through the Gli2-YAP1 axis via regulation of anoikis.
Yu B, Gu D, Zhang X, Liu B, Xie J Genes Dis. 2022; 9(6):1427-1430.
PMID: 36157479 PMC: 9485280. DOI: 10.1016/j.gendis.2022.05.010.
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming.
Adeshakin F, Adeshakin A, Afolabi L, Yan D, Zhang G, Wan X Front Oncol. 2021; 11:626577.
PMID: 33854965 PMC: 8039382. DOI: 10.3389/fonc.2021.626577.
Chen F, Zhong Z, Tan H, Guo W, Zhang C, Tan C Front Pharmacol. 2020; 11:293.
PMID: 32256363 PMC: 7093640. DOI: 10.3389/fphar.2020.00293.
Hu B, An H, Yan X, Zheng J, Huang X, Li M BMC Complement Altern Med. 2019; 19(1):67.
PMID: 30876428 PMC: 6420768. DOI: 10.1186/s12906-019-2477-9.